Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents (Q24202221)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6599878&resulttype=core&format=json

15 May 2020

Matthew Leach

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6599878&resulttype=core&format=json

15 May 2020

author name string

Sagar S Lad

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6599878&resulttype=core&format=json

15 May 2020

Melissa J Ross

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6599878&resulttype=core&format=json

15 May 2020

John Kh Sinn

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6599878&resulttype=core&format=json

Cochrane Database of Systematic Reviews

15 May 2020

language of work or name

English

0 references

publication date

11 July 2012

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6599878&resulttype=core&format=json

15 May 2020

page(s)

CD007986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6599878&resulttype=core&format=json

15 May 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6599878&resulttype=core&format=json

Omega-3 fatty acid treatment of children with attention-deficit hyperactivity disorder: A randomized, double-blind, placebo-controlled study

15 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

The effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder-a placebo-controlled double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

Effect of docosahexaenoic acid-containing food administration on symptoms of attention-deficit/hyperactivity disorder - a placebo-controlled double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

Omega-3/omega-6 fatty acids for attention deficit hyperactivity disorder: a randomized placebo-controlled trial in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

The influence of short-chain essential fatty acids on children with attention-deficit/hyperactivity disorder: a double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

Effect of supplementation with polyunsaturated fatty acids and micronutrients on learning and behavior problems associated with child ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

Supplementation with flax oil and vitamin C improves the outcome of Attention Deficit Hyperactivity Disorder (ADHD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

A randomized double-blind, placebo-controlled study of the effects of supplementation with highly unsaturated fatty acids on ADHD-related symptoms in children with specific learning difficulties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

Role of long-chain polyunsaturated fatty acids in the first year of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

Fish oil and mental health: the role of n-3 long-chain polyunsaturated fatty acids in cognitive development and neurological disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

Attention-deficit/hyperactivity disorder: a selective overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

The role of polyunsaturated fatty acids (PUFAs) in development, aging and substance abuse disorders: review and propositions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

Attention deficit disorder: a review of the past 10 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

Dietary patterns and blood fatty acid composition in children with attention-deficit hyperactivity disorder in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

Update on attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

Genetics of childhood disorders: XX. ADHD, Part 4: is ADHD genetically heterogeneous?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

Update on environmental risk factors for attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

What is attention-deficit hyperactivity disorder (ADHD)?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

Is there evidence for biased reporting of published adverse effects data in pharmaceutical industry-funded studies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

Essential fatty acids and the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

Suicidality in pediatric patients treated with antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

The role of dietary n-6 and n-3 fatty acids in the developing brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

Attention-deficit hyperactivity disorder in children and youth: a quantitative systematic review of the efficacy of different management strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

Pharmaceutical industry sponsorship and research outcome and quality: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

Clinical characteristics and serum essential fatty acid levels in hyperactive children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

Parenting and the development of conduct disorder and hyperactive symptoms in childhood: a prospective longitudinal study from 2 months to 8 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

The economic impact of attention-deficit/hyperactivity disorder in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

The worldwide prevalence of ADHD: a systematic review and metaregression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

Essential fatty acids and attention-deficit-hyperactivity disorder: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

The potential role of fatty acids in attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

Clinical trials of fatty acid treatment in ADHD, dyslexia, dyspraxia and the autistic spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

Omega-3 fatty acids in ADHD and related neurodevelopmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

Do artificial food colors promote hyperactivity in children with hyperactive syndromes? A meta-analysis of double-blind placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

Pharmacotherapy of attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

Longchain polyunsaturated fatty acid supplementation in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

Longchain polyunsaturated fatty acid supplementation in infants born at term

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

Oiling the brain: a review of randomized controlled trials of omega-3 fatty acids in psychopathology across the lifespan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

Attention deficit/hyperactivity disorder children with a 7-repeat allele of the dopamine receptor D4 gene have extreme behavior but normal performance on critical neuropsychological tests of attention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

Do essential fatty acids play a role in brain and behavioral development?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

Pre-, peri-, and postnatal trauma in subjects with attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder

21 January 2018

1 reference

12 December 2020

National Institutes of Health Consensus Development Conference Statement: diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD)

1 reference

12 December 2020

Does zinc moderate essential fatty acid and amphetamine treatment of attention-deficit/hyperactivity disorder?

1 reference

12 December 2020

Outcome-based comparison of Ritalin versus food-supplement treated children with AD/HD.

1 reference

12 December 2020

Does stimulant treatment lead to substance use disorders?

1 reference

12 December 2020

Non-stimulant medications in the treatment of ADHD.

1 reference

12 December 2020

The effect of ADHD on the life of an individual, their family, and community from preschool to adult life

1 reference

12 December 2020

Maternal smoking during pregnancy as an environmental risk factor for attention deficit hyperactivity disorder behaviour. A review

1 reference

12 December 2020

The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis

1 reference

12 December 2020

Polyunsaturated Fatty Acid Supplementation for ADHD Symptoms: Response to Commentary

1 reference

12 December 2020

Correlation between changes in blood fatty acid composition and visual sustained attention performance in children with inattention: effect of dietary n-3 fatty acids containing phospholipids.

1 reference

12 December 2020

Cognitive effects of polyunsaturated fatty acids in children with attention deficit hyperactivity disorder symptoms: A randomised controlled trial

1 reference

12 December 2020

Omega-3 fatty acids in health and disease and in growth and development

1 reference

12 December 2020

The effect of phosphatidylserine containing Omega3 fatty-acids on attention-deficit hyperactivity disorder symptoms in children: a double-blind placebo-controlled trial, followed by an open-label extension

1 reference

12 December 2020

Gamma-linolenic acid for attention-deficit hyperactivity disorder: placebo-controlled comparison to D-amphetamine

1 reference

12 December 2020

A twin study of hyperactivity--II. The aetiological role of genes, family relationships and perinatal adversity

1 reference

12 December 2020

The effects of essential fatty acid supplementation by Efamol in hyperactive children

1 reference

12 December 2020

Neurochemical correlates of attention deficit disorder

1 reference

12 December 2020

Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder

1 reference

12 December 2020

Detecting skewness from summary information

1 reference

12 December 2020

Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism

1 reference

12 December 2020

Attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Psychopharmacology of ADHD: children and adolescents

1 reference

12 December 2020

Revision and restandardization of the Conners Teacher Rating Scale (CTRS-R): factor structure, reliability, and criterion validity

1 reference

12 December 2020

A conceptual framework for the revision of the ICD-10 classification of mental and behavioural disorders

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

7 January 2021

inferred from DOI database lookup

Attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007986.PUB2

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/14651858.CD007986.PUB2

2 references

Consolidated OpenCitations Corpus – April 2017

345983

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6599878&resulttype=core&format=json

15 May 2020

345983

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6599878&resulttype=core&format=json

15 May 2020

2 references

Consolidated OpenCitations Corpus – April 2017

345983